I'm on your side 1000%

First 32 Last

Share
Profile

Follow
vickers

64 Posts.

1

06/08/22

11:44

Post #: 62961076
Share

Originally posted by TheSanDiegoKid: ↑

The covid detection market will be worth +$100B!!!
Not sure how many of you remember the conference call back in March after the company first announced positive results of the covid detection app.

That call featured Professor Catherine Bennett, Chair of Epidemiology at Deakin University. She went on to state how not only "The simplicity, ease of use and unlimited scalability of ResApp’s test will be welcomed by public health officials around the world.” - But that the global covid diagnostic market is predicted to reach in excess of $100B USD annually by 2027 (less than five years away).

And some people are happy to sell the most disruptive tech and data set in this space for approx 1/1000th of that annual revenue... WHY?!!!!Let's not lose focus on what is happening here. One of the world's most powerful and wealthy companies wants to essentially steal this tech to reap the rewards themselves, and they have tried their best to package it as a good deal for the share holders in order to convince them this is our best option.

Imagine what this could be worth when we stick to the No vote and accept only a partnership deal with them or another appropriate candidate!!!

I'd imagine a decent chunk of that $100B would be having a bit of an impact on the future share price.

Even if we captured 1/1000th of that potential market, we'd be making a year what they are trying to convince us the entire business is worth!

And then ofc there is Dx and Sleepcheck to add to the mix.

Let's go shareholders! Vote No!!!!!!

Expand

I'm on your side 1000%

RAP Price at posting: 19.0¢ Sentiment: Hold Disclosure: Held
4 Upvote

0 Great analysis

Reply

Top Stories

PEC

Perpetual sniffs TREOs beyond 4000ppm at Raptor play in Brazil

MM1

Geochemical work at Newington picks up gold and copper anomalies for Midas

Capital raisings wrap: Brainchip, Ovanti, Lake and VHM

TRP

Tissue Repairs soars nearly 32% on TGA approval for wound healing gel

BGL

Bellevue aims for 45% production increase by FY 2028, announces $150M placement